Camptothecin analog (CPT-11)-sensitive human pancreatic tumor cell line QGP-1N shows resistance to SN-38, an active metabolite of CPT-11

This publication has 9 references indexed in Scilit:

• Differential expression of DNA topoisomerase I gene between CPT-11 acquired-and native-resistant human pancreatic tumor cell lines: Detected by RNAPCR-based quantitation assay
  Biochemical and Biophysical Research Communications, 1992
• Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites
  Nucleic Acids Research, 1991
• Pancreastatin producing cell line from human pancreatic islet cell tumor
  Biochemical and Biophysical Research Communications, 1990
• On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex
  Biochemistry, 1989
• Inhibition of spontaneous and experimental metastasis by a new derivative of camptothecin, CPT-11, in mice
  Cancer Chemotherapy and Pharmacology, 1988
• Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo
  Cancer Chemotherapy and Pharmacology, 1988
• Effects of camptothecin on RNA synthesis in leukemia L1210 cells
  Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1971
• Camptothecin inhibits macromolecular synthesis in mammalian cells but not in isolated mitochondria or lE. coli
  Biochemical and Biophysical Research Communications, 1970
• Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata^1,2
  Journal of the American Chemical Society, 1966